| 000 | 01697 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250513170446.0 | ||
| 264 | 0 | _c19990415 | |
| 008 | 199904s 0 0 jpn d | ||
| 022 | _a0485-1439 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aYamazaki, T | |
| 245 | 0 | 0 |
_a[Clinical outcomes in low grade follicular lymphoma]. _h[electronic resource] |
| 260 |
_b[Rinsho ketsueki] The Japanese journal of clinical hematology _cJan 1999 |
||
| 300 |
_a1-8 p. _bdigital |
||
| 500 | _aPublication Type: English Abstract; Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 |
_aBleomycin _xadministration & dosage |
| 650 | 0 | 4 | _aCombined Modality Therapy |
| 650 | 0 | 4 |
_aCyclophosphamide _xadministration & dosage |
| 650 | 0 | 4 |
_aDoxorubicin _xadministration & dosage |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLeucovorin _xadministration & dosage |
| 650 | 0 | 4 |
_aLymphoma, Follicular _xmortality |
| 650 | 0 | 4 |
_aLymphoma, Non-Hodgkin _xmortality |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMethotrexate _xadministration & dosage |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPrednisone _xadministration & dosage |
| 650 | 0 | 4 | _aRadiotherapy Dosage |
| 650 | 0 | 4 | _aSurvival Rate |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aVincristine _xadministration & dosage |
| 700 | 1 | _aKura, Y | |
| 700 | 1 | _aSato, Y | |
| 700 | 1 | _aIrie, T | |
| 700 | 1 | _aKaneita, Y | |
| 700 | 1 | _aMochimaru, J | |
| 700 | 1 | _aHanai, M | |
| 700 | 1 | _aYasukawa, K | |
| 700 | 1 | _aSawada, U | |
| 700 | 1 | _aHorie, T | |
| 773 | 0 |
_t[Rinsho ketsueki] The Japanese journal of clinical hematology _gvol. 40 _gno. 1 _gp. 1-8 |
|
| 999 |
_c10027200 _d10027200 |
||